Morning Overview on MSN
Mini human livers can now predict drug toxicity
Scientists have achieved a groundbreaking advancement in preclinical testing by growing mini human livers, known as organoids, that can predict toxic drug reactions. This significant development, ...
An international project to create a "digital twin" of the human immune system could help scientists finally tackle grand ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
Researchers at Cincinnati Children’s Hospital Medical Center, in collaboration with Roche, have developed a next-generation ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
News-Medical.Net on MSN
UC Irvine develops human-like colon model for precision medicine
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery.
Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...
For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results